Seners et al Ann Neurol. 2020


 

Seners P, Perrin C, Lapergue B, Henon H, Debiais S, Sablot D, Girard-Buttaz I, Tamazyan R, Preterre C, Laksiri N, Mione G, Arquizan C, Lucas L, Baron JC, Turc G. Bridging therapy or IV thrombolysis in minor stroke with large vessel occlusion. Ann Neurol. 2020 Apr 29;. doi: 10.1002/ana.25756. [Epub ahead of print] PubMed PMID: 32350929. Download from HAL-INSERM

 

OBJECTIVE:

Whether bridging therapy (intravenous thrombolysis [IVT] followed by endovascular treatment) is superior to IVT alone in minor stroke with large vessel occlusion (LVO) is unknown.

METHODS:

Multicentric retrospective observational study including, in intention-to-treat, consecutive IVT-treated minor strokes (National Institutes of Health Stroke Scale [NIHSS] ≤ 5) with LVO, with or without additional mechanical thrombectomy. Propensity-score (inverse probability of treatment weighting) was used to reduce baseline between-groups differences. The primary outcome was excellent outcome, that is, modified Rankin score 0 to 1 at 3 months follow-up.

RESULTS:

Overall, 598 patients were included (214 and 384 in the bridging therapy and IVT groups, respectively). Following propensity-score weighting, the distribution of baseline clinical and radiological variables was similar across the two patient groups. Compared with IVT alone, bridging therapy was not associated with excellent outcome (odds ratio [OR] = 0.96; 95% confidence interval [CI] = 0.75-1.24; p = 0.76), but was associated with symptomatic intracranial hemorrhage (OR = 3.01; 95% CI = 1.77-5.11; p < 0.0001). Occlusion site was a strong modifier of the effect of bridging therapy on outcome (pinteraction < 0.0001), with bridging therapy associated with higher odds of excellent outcome in proximal M1 (OR = 3.26; 95% CI = 1.67-6.35; p = 0.0006) and distal M1 (OR = 1.69; 95% CI = 1.01-2.82; p = 0.04) occlusions, but with lower odds of excellent outcome for M2 (OR = 0.53; 95% CI = 0.38-0.75; p = 0.0003) occlusions. Bridging therapy was associated with higher rates of symptomatic intracranial hemorrhage in M2 occlusions only (OR = 4.40; 95% CI = 2.20-8.83; p < 0.0001).

INTERPRETATION:

Although overall outcomes were similar in intended bridging therapy as compared to intended IVT alone in minor strokes with LVO, our results suggest that intended bridging therapy may be beneficial in M1 occlusions, whereas the benefit-risk profile may favor IVT alone in M2 occlusions. ANN NEUROL 2020.

This part of the website could either be in French or English, depending on the sources of the actualities.

SIDEBAR_ARCHIVE_TITLE

 01 décembre 2023
IPNP Seminar Friday December 1st, dr Julie GAVARD Glioblastoma cells walk the line with brain vessels
 28 novembre 2023
12h30 de la recherche - 28 novembre-Grand Amphi Blanc GHU Sainte-Anne-IPNP
 06 octobre 2023
IPNP Seminar Friday October 6th, Pr Angeliki LOUVI: Investigating Brain Disease: from Patients to Model Organisms and Beyond
 26 septembre 2023
12h30 de la recherche - 26 septembre-Grand Amphi Blanc GHU Sainte-Anne-IPNP
 06 septembre 2023
IPNP Seminar September 6th, Dr Daniel Medina Cano, A stem cell platform to map cell type and stage-specific cis-regulatory variation in mouse embryonic brain development
 01 septembre 2023
IPNP Seminar Friday September 1st, Pr Annika KELLER, Vascular calcification in the brain
 25 août 2023
Seminar Friday August 25th, Dr Mariana Tasso: Nanobiomaterials: from the beauties of the nanoworld to the quest for real biological applications
 07 juillet 2023
Friday, July 7th, 2023, noon: Dr Sophie STECULORUM (Host V Tolle) Max Planck Institute, Köln, Germany Sensory regulation of feeding behaviour and metabolism
 02 juin 2023
IPNP Seminar June 2nd Noon Pr Christian NOLTE: Myocardial injury in acute ischemic stroke – from heart to brain and back again
 30 mai 2023
12h30 de la recherche - 30 mai-Amphi Morel GHU Sainte-Anne-IPNP
 25 avril 2023
Hemorrhagic Stroke: Current Research regarding Etiological Diagnosis
 07 avril 2023
IPNP Seminar noon friday April 7th 2023: Pr Ype ELGERSMA-Mechanisms underlying Angelman syndrome and the promise of antisense oligonucleotide (ASO) treatment
 17 mars 2023
Mitochondria and the social organelle network
 01 mars 2023 20 mars 2023
Semaine du Cerveau 25ème édition
 01 mars 2023 14 mars 2023
Conférence inaugurale de la Semaine du Cerveau: Neurosciences et Psychiatrie, un vertueux mariage
 24 février 2023 18 mars 2023
NeuroFrance 2023
 02 septembre 2022
The reciprocal interplay between nutrient sensing and secretory pathways defines cellular homeostasis
 01 juillet 2022
Cortical wiring by synapsespecific control of local protein synthesis
 20 juin 2022
Demars et al. Curr Biol. 2022
 10 juin 2022
A "Neurotour de France" - Ep. 2, présentation of IPNP